Joseph M Gullett1,2, Ronald A Cohen1,2, Gee Su Yang3, Victoria S Menzies4, Robert A Fieo1,5, Debra L Kelly3, Angela R Starkweather6, Colleen K Jackson-Cook7, Debra E Lyon3. 1. Center for Cognitive Aging and Memory, McKnight Brain Institute, University of Florida, Gainesville, Florida. 2. Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida. 3. College of Nursing, University of Florida, Gainesville, Florida. 4. School of Nursing, Virginia Commonwealth University, Richmond, Virginia. 5. Department of Aging and Geriatric Research, University of Florida, Gainesville, Florida. 6. School of Nursing, University of Connecticut, Storrs, Connecticut. 7. Department of Pathology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
Abstract
OBJECTIVE: Fatigue and cognitive dysfunction are major concerns for women with early-stage breast cancer during treatment and into survivorship. However, interrelationships of these phenomena and their temporal patterns over time are not well documented, thus limiting the strategies for symptom management interventions. In this study, changes in fatigue across treatment phases and the relationship among fatigue severity and its functional impact with objective cognitive performance were examined. METHODS: Participants (N = 75) were assessed at five time points beginning prior to chemotherapy to 24 months after initial chemotherapy. Fatigue severity and impact were measured on the Brief Fatigue Inventory. Central nervous system (CNS) Vital Signs was used to measure performance based cognitive testing. Temporal changes in fatigue were examined, as well as the relationship between fatigue and cognitive performance, at each time point using linear mixed effect models. RESULTS: Severity of fatigue varied as a function of phase of treatment. Fatigue severity and its functional impact were moderate at baseline, increased significantly during chemotherapy, and returned to near baseline levels by 2 years. At each time point, fatigue severity and impact were significantly associated with diminished processing speed and complex attention performance. CONCLUSIONS: A strong association between fatigue and objective cognitive performance suggests that they are likely functionally related. That cognitive deficits were evident at baseline, whereas fatigue was more chemotherapy dependent, implicates that two symptoms share some common bases but may differ in underlying mechanisms and severity over time. This knowledge provides a basis for introducing strategies for tailored symptom management that vary over time.
OBJECTIVE:Fatigue and cognitive dysfunction are major concerns for women with early-stage breast cancer during treatment and into survivorship. However, interrelationships of these phenomena and their temporal patterns over time are not well documented, thus limiting the strategies for symptom management interventions. In this study, changes in fatigue across treatment phases and the relationship among fatigue severity and its functional impact with objective cognitive performance were examined. METHODS:Participants (N = 75) were assessed at five time points beginning prior to chemotherapy to 24 months after initial chemotherapy. Fatigue severity and impact were measured on the Brief Fatigue Inventory. Central nervous system (CNS) Vital Signs was used to measure performance based cognitive testing. Temporal changes in fatigue were examined, as well as the relationship between fatigue and cognitive performance, at each time point using linear mixed effect models. RESULTS: Severity of fatigue varied as a function of phase of treatment. Fatigue severity and its functional impact were moderate at baseline, increased significantly during chemotherapy, and returned to near baseline levels by 2 years. At each time point, fatigue severity and impact were significantly associated with diminished processing speed and complex attention performance. CONCLUSIONS: A strong association between fatigue and objective cognitive performance suggests that they are likely functionally related. That cognitive deficits were evident at baseline, whereas fatigue was more chemotherapy dependent, implicates that two symptoms share some common bases but may differ in underlying mechanisms and severity over time. This knowledge provides a basis for introducing strategies for tailored symptom management that vary over time.
Authors: Debra E Lyon; Ronald Cohen; Huaihou Chen; Debra L Kelly; Angela Starkweather; Hyo-Chol Ahn; Colleen K Jackson-Cook Journal: J Cancer Res Clin Oncol Date: 2016-04-21 Impact factor: 4.553
Authors: Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2016-06-02 Impact factor: 508.702
Authors: Jeanne S Mandelblatt; Robert A Stern; Gheorghe Luta; Meghan McGuckin; Jonathan D Clapp; Arti Hurria; Paul B Jacobsen; Leigh Anne Faul; Claudine Isaacs; Neelima Denduluri; Brandon Gavett; Tiffany A Traina; Patricia Johnson; Rebecca A Silliman; R Scott Turner; Darlene Howard; John W Van Meter; Andrew Saykin; Tim Ahles Journal: J Clin Oncol Date: 2014-05-19 Impact factor: 44.544
Authors: Sanne Menning; Michiel B de Ruiter; Dick J Veltman; V Koppelmans; Clemens Kirschbaum; Willem Boogerd; Liesbeth Reneman; Sanne B Schagen Journal: Neuroimage Clin Date: 2015-02-20 Impact factor: 4.881
Authors: Carmen Kohler; Ming Chang; Yu-Yin Allemann-Su; Marcus Vetter; Miyeon Jung; Misook Jung; Yvette Conley; Steven Paul; Kord M Kober; Bruce A Cooper; Betty Smoot; Jon D Levine; Christine Miaskowski; Maria C Katapodi Journal: J Pain Symptom Manage Date: 2020-01-15 Impact factor: 3.612
Authors: Nicole Rodriguez; Jonathan M Fawcett; Joshua A Rash; Renee Lester; Erin Powell; Connor D MacMillan; Sheila N Garland Journal: Cancer Med Date: 2021-01-16 Impact factor: 4.452
Authors: A M Ter Haar; M M Nap-van der Vlist; M Van den Hof; S L Nijhof; R R L van Litsenburg; K J Oostrom; D Pajkrt Journal: BMC Pediatr Date: 2021-11-20 Impact factor: 2.125
Authors: Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler Journal: Oncologist Date: 2021-07-12
Authors: Jeanne S Mandelblatt; Wanting Zhai; Jaeil Ahn; Brent J Small; Tim A Ahles; Judith E Carroll; Neelima Denduluri; Asma Dilawari; Martine Extermann; Deena Graham; Arti Hurria; Claudine Isaacs; Paul B Jacobsen; Heather S L Jim; George Luta; Brenna C McDonald; Sunita K Patel; James C Root; Andrew J Saykin; Danielle B Tometich; Xingtao Zhou; Harvey J Cohen Journal: Cancer Date: 2019-12-20 Impact factor: 6.921